Skip to contentGlobal Market Access Lead – Entyvio/IBD
Company | Takeda |
---|
Location | Cambridge, MA, USA |
---|
Salary | $174500 – $274230 |
---|
Type | Full-Time |
---|
Degrees | Bachelor’s |
---|
Experience Level | Senior, Expert or higher |
---|
Requirements
- Bachelor’s degree required
- 10+ years pharmaceutical/biotech experience
- Minimum 5 years of market access experience
- Experience developing market access strategies at a global and local level including pricing, reimbursement and access
- Immunology experience
- Experience with global markets and payer environment (e.g. HTAs, payer coverage and reimbursement, pricing and contracting, formulary management, health technology assessment and payment policy)
- Direct experience in payer negotiations desirable
Responsibilities
- Deliver Market Access tactics for Entyvio and other assets from GI Inflammation portfolio to ensure successful pricing negotiations and reimbursement in countries
- Provide a single contact for all market access needs and activities for assigned products/indications within Therapeutic Area Franchise
- Provide early input into clinical development programs for Entyvio and pipeline products to ensure the right evidence is collected to support reimbursement and pricing negotiations
- Contribute to Entyvio late lifecycle planning to ensure continued value recognition and support readiness considering the competitive IBD space
- Understand the access and payer needs and propose strategic, implementable solutions to support reimbursement, sustainable value and patient access
- Be an active member of a Global Pricing and Access team within selected Global Product Teams that develop and deliver an integrated patient access and value strategy for all early assets and BD products based on an understanding of the science and disease, patient and care giver needs, and the evolving payer landscape and evidence requirements
- Partner with major countries, regional access teams and Global Market Insights teams to ensure that the market access and value strategy contributes to the definition of the asset strategy of each relevant pipeline product so that at launch (and beyond) the product delivers the value proposition most relevant to payers and is supported by a global value story, compelling evidence package, and pricing strategy to maximize both patient access and the life-time value of the product
- Work with GHE & Pricing colleagues to ensure ‘one Team one voice’ within the entire organization
- Assess important possible effects of post-launch inflection points and obtain appropriate payer and reimbursement strategies
- Evaluate and influence evidence generation plans by summarizing payer/HTA insights
- Support GPA preparation to all main governance meetings (PRC, CLC)
- Develop the global, integrated Market Access Plan (TVP in collaboration with GHE, Evidence, Strategic Pricing, Partner Engagement and LOC Implementation) and implement Access deliverables to achieve successful reimbursement and pricing for Takeda’s assigned Therapeutic Area products
- Develop access frameworks that consider and anticipate the evolving health care environment to create win-win-win situations for patients, payers and Takeda
- Lead horizon scanning and in-depth understanding of payer regulations and priorities, and the needs of all payer types (e.g. HTA agencies, institutions and patients) across major countries and arche-types
- Collaborate with Regions and Local Operating Companies (LOCs) to ensure external payer focus and recent trends in Therapeutic Area are incorporated into Global asset strategy, and lead training programs to enhance the understanding of Market Access with important team members
Preferred Qualifications
- Direct experience in payer negotiations desirable